VIB vzw

ALPHATAC

Pharmaceutical, medical and veterinary preparations for the treatment of cardiovascular diseases, allergies, immune and inflammatory diseases, metabolic diseases, cancer, diseases of the central nervous system, musculoskeletal diseases, ophthalmological diseases, and infectious diseases in humans and livestock; diagnostics preparations for medical and veterinary purposes and diagnostic materials, namely, diagnostic reagents and media for diagnosing cardiovascular diseases, allergies, immune and inflammatory diseases, metabolic diseases, cancer, diseases of the central nervous systems, musculoskeletal diseases, ophthalmological diseases, and infectious diseases in humans and livestock; pharmaceutical preparations, being bioculture preparations for the treatment of cardiovascular diseases, allergies, immune and inflammatory diseases, metabolic diseases, cancer, diseases of the central nervous system, musculoskeletal diseases, ophthalmological diseases, and infectious diseases in humans and livestock; veterinary diagnostic reagents and diagnostic reagents for medicinal use, namely, preparations and substances for use in drug discovery and structural biology, namely, proteins and protein conjugates in raw material form or as formulated reagents;Science and technology services, namely, technical consultancy and research in the fields of drug discovery, structural biology research, and biotechnology research; science and technology services, namely, scientific and laboratory research in the medical, bacteriological, biotechnical, pharmaceutical and diagnostic fields; natural science services, namely, research in the field of structural biology, engineering, and biotechnology; medical and pharmacological research services; clinical research in the fields of cardiovascular diseases, allergies, immune and inflammatory diseases, metabolic diseases, cancer, diseases of the central nervous system, and infectious diseases; clinical research in the fields of medical and biotechnological procedures, namely, radiology, chemotherapy and in vivo imaging; medical laboratories; conducting early evaluations in the field of new pharmaceuticals; consultancy relating to pharmaceutical research and development; drug discovery services; laboratory services relating to the production of proteins and protein conjugates; information technology services for the pharmaceutical and healthcare industries;

MEGABODY

Medical and veterinary preparations for the treatment of cardiovascular diseases, allergies, immune and inflammatory diseases, metabolic diseases, cancer, diseases of the central nervous system, and infectious diseases in humans and livestock; diagnostic preparations for medical and veterinary purposes and diagnostic materials, namely, diagnostic reagents and media for diagnosing cardiovascular diseases, allergies, immune and inflammatory diseases, metabolic diseases, cancer, diseases of the central nervous systems, and infectious diseases in humans and livestock; pharmaceutical preparations for the treatment of cardiovascular diseases, allergies, immune and inflammatory diseases, metabolic diseases, cancer, diseases of the central nervous system, and infectious diseases in humans and livestock; veterinary diagnostic reagents and diagnostic reagents for medicinal use, namely, proteins for use in drug discovery and structural biology, namely, proteins, protein conjugates, and antibodies in raw material form or as formulated reagents; all of the aforesaid goods excluding dental impression materials;MEGA BODY;Proteins for use in drug discovery and structural biology, namely, proteins, protein conjugates, and antibodies in raw material form or as formulated reagents, all for scientific, medical and biotechnological research;Science and technology services, namely, technical consultancy and research in the fields of drug discovery, structural biology research, and biotechnology research; science and technology services, namely, scientific and laboratory research in the medical, bacteriological, biotechnical and diagnostic fields; natural science services, namely, research in the field of structural biology, engineering, and biotechnology; medical and pharmacological research services; clinical research in the fields of cardiovascular diseases, allergies, immune and inflammatory diseases, metabolic diseases, cancer, diseases of the central nervous system, and infectious diseases; clinical research in the fields of medical and biotechnological procedures, namely, radiology, chemotherapy and in vivo imaging; medical laboratories; conducting early evaluations in the field of new pharmaceuticals; consultancy relating to pharmaceutical research and development; drug discovery services; laboratory services relating to the production of antibodies; information technology services for the pharmaceutical and healthcare industries; all of the aforesaid services not relating to dental impression materials;

NERF

The mark consists of the word NERF in stylized font where the letters N, R and F appear in blue and the letter E appears in green. There is a half circle extending from the letter N around to the right below the letter R composed of several small blue circles and three larger green circles where the larger green circles appear above the letter N, above the letter R and to the right of the letter F.;The color(s) green and blue is/are claimed as a feature of the mark.;Research and development in the field of neuroscience and neuroelectronics;